SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0000909012-04-000097
Filing Date
2004-02-13
Accepted
2004-02-13 17:05:29
Documents
5
Period of Report
2003-10-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT (10/31/03) t300808.txt 10KSB 227819
3 CERTIFICATION OF CEO exh31-1.txt EX-31.1 3071
4 CERTIFICATION OF CFO exh31-2.txt EX-31.2 3044
5 CERTIFICATION OF CEO exh32-1.txt EX-32.1 1410
6 CERTIFICATION OF CFO exh32-2.txt EX-32.2 1410
  Complete submission text file 0000909012-04-000097.txt   238902
Mailing Address 73-4460 QUEEN KA'AHUMANU HWY. SUITE 110 KAILUA-KONA HI 96740
Business Address 73-4460 QUEEN KA'AHUMANU HWY. SUITE 110 KAILUA-KONA HI 96740 (808) 326-9301
MERA PHARMACEUTICALS INC (Filer) CIK: 0000837490 (see all company filings)

IRS No.: 043683628 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10KSB | Act: 34 | File No.: 033-23460 | Film No.: 04600223
SIC: 8731 Services-Commercial Physical & Biological Research